Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Genetic Technologies Limited GENE NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Diagnostics & Research • AU • USD

SharesGrow Score
29/100
0/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Genetic Technologies Limited (GENE) has 11 identified peers for comparison in the Healthcare sector. Peers include A, BIAF, BIOC, HTGM, IDXG, INBS and others.

GENE has a market capitalization of $111.24M, compared to an average peer market cap of $3.12B. GENE is notably smaller than its average peer.

People Also View

A
A
Agilent Technologies, Inc.
$120.40
+2.47%
 MDXH
MDXH
MDxHealth SA
$2.27
+6.07%
 SERA
SERA
Sera Prognostics, Inc.
$2.14
+0.47%
 PRPO
PRPO
Precipio, Inc.
$28.50
+1.60%
 BIAF
BIAF
bioAffinity Technologies, Inc.
$2.81
-11.64%
 IDXG
IDXG
Interpace Biosciences, Inc.
$2.20
-4.35%
 SQL
SQL
SeqLL Inc.
$6.60
-2.38%
 INBS
INBS
Intelligent Bio Solutions Inc.
$2.77
+12.60%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message